Rosen Law Firm is notifying investors who purchased or otherwise acquired Microvast Holdings, Inc. securities from April 1, 2025, through March 16, 2026, about a filed securities class action and the September 21, 2026, deadline to seek appointment as lead plaintiff. The lawsuit alleges Microvast overstated its ability to meet margin targets and complete the Huzhou Phase 3.2 manufacturing expansion by the end of 2025, while failing to disclose inventory-management problems and delays in customers’ commercial-vehicle rollouts. Earlier case materials said Microvast’s fourth-quarter and full-year 2025 gross margin declined from 2024, primarily because of a $32.5 million impairment charge related to specialized ESS components. Quarterly gross margin was reported at approximately 1%, versus approximately 36% a year earlier, while revenue was $96.5 million, down 15% year over year. Investors do not need to seek lead-plaintiff status to participate in any potential recovery. No class has been certified, and investors may retain counsel, remain absent class members, or take no action at this stage.